Two Sigma Investments, LP Igm Biosciences, Inc. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 139,770 shares of IGMS stock, worth $178,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,770
Previous 107,620
29.87%
Holding current value
$178,905
Previous $657,000
75.65%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IGMS
# of Institutions
80Shares Held
15.8MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5.24 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.17 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.78 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.12 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.1M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...